Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1HIV Infections 1Dendritic Cell Sarcoma, Interdigitating 1B-cell Tumors 1

Interventions

Rituximab 1401Cyclophosphamide 1306Vincristine 668Doxorubicin 587Etoposide 527Prednisone 511Cytarabine 486fludarabine 470Methotrexate 445Dexamethasone 413fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 282Radiotherapy 267venetoclax 261ibrutinib 258obinutuzumab 236Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 162Magnetic Resonance Spectroscopy 155Calcium Dobesilate 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
efavirenz × Lymphoid × Clear all
NCT05560360 2023-02-02

A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
20 enrolled
Lymphoid

B-cell Tumors

NCT01878890 2021-01-27

ESCALE

Institut Bergonié

Phase 1 Completed
25 enrolled 11 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00799136 2013-09-12

CATCH

Ontario Clinical Oncology Group (OCOG)

Phase 2 Completed
6 enrolled
LymphoidSarcoma

HIV Infections, Lymphoma, AIDS-Related, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡